TO PUT IT BRIEFLY

People continue to die in hospitals from treatable infectious diseases How can we reduce the loss of lives? Through an 80% reduction in the time doctors have to wait for the diagnostic results of the correct antibiotic treatment (AST) Cutting-edge patent(*) technology that employs laser beam interference patterns to accurately measure the density of bacteria cultures People continue to die in hospitals from treatable infectious diseases How can we reduce the loss of lives? Through an 80% reduction in the time doctors have to wait for the diagnostic results of the correct antibiotic treatment (AST) Cutting-edge patent(*) technology that employs laser beam interference patterns to accurately measure the density of bacteria cultures
img
Challenge The problem About Us Solutions Market Ask Time Counts Roadmap Briefly img 00:30

We are phenofAST,

and we are redefining the timeline of life-saving antibiotics with precise
AST What is AST (Antibiotic Susceptibility Test)? AST measures the response of bacteria to various antibiotics. The aim is to find the smallest concentration of antibiotics that can stop the growth of a particular culture. The physician successfully makes a correct clinical decision regarding the appropriate antibiotic treatment, using AST data. results available in just 4 hours. We are here to change the narrative,
to transform lives, and to revolutionize the health sector. Join us in this
life-changing mission. Let us together redefine the health sector timeline
and save more lives. Because time counts.

img
Challenge The problem About Us Solutions Market Ask Time Counts Roadmap Briefly img 00:30
The problem

Lives are still being lost in hospitals to severe infectious
diseases that can be effectively treated.

The process of testing and determining the appropriate antibiotic treatment for a patient's infection can take up to 5 days 50% of antibiotic prescriptions are incorrect (physician's educated guess) Increasing occurrence of antibiotic-resistant bacteria Every 10 minutes, a person meets an avoidable death
The process of testing and determining the appropriate antibiotic treatment for a patient's infection can take up to 5 days 50% of antibiotic prescriptions are incorrect (physician's educated guess) Every 10 minutes, a personmeets an avoidable death Increasing occurrence of antibiotic-resistant bacteria
img
Challenge The problem About Us Solutions Market Ask Time Counts Roadmap Briefly img 01:00
Challenge

To arm doctors with the
right tools to act swiftly and
accurately, thereby saving
more lives.

img
Challenge The problem About Us Solution Market Ask Time Counts Roadmap img 01:30
Solution

The phenofAST analyzer utilizes physics-based technology to deliver AST
results in a time frame of just 4 hours (after culture-positive result).

Plate Culturing Plate Culturing BacteriaID BacteriaID Doctor’s Report StandardLab Work StandardLab Work phenofAST + 48h-72h AST AST Blood Culturing Blood Culturing Patient’s Sample Timeline 12h 4h 16h Days 5 up to Same Day Result Plate Culturing Plate Culturing Bacteria ID Bacteria ID AST Doctor’s Report Standard Lab Work Standard Lab Work + phenofAST AST Blood Culturing Blood Culturing Patient’ssample 12h 48h-72h 4h 16h 5Days Same Day Result up to
img
Challenge The problem About Us Solution Market Ask Time Counts Roadmap img 02:00
MARKET $36 billion $2.5 billion $250 million (in 5 years) SOM SAM TAM Total Available Market Serviceable Available Market Serviceable Obtainable Market -2 0 1 2 3 4 5 0 2 4 6 8 10 12 Market Share (%) Years $ millions 23 48 73 98 123 148 173 198 223 248 273 Market Share Gross Revenue ($M) Net Revenue ($M) Revenue Forecast MARKET SOM SAM TAM $36 billion $2.5 billion $250 million (in 5 years) Total Available Market Serviceable Available Market Serviceable Obtainable Market -2 0 1 2 3 4 5 0 2 4 6 8 10 12 Market Share (%) Years $ millions 23 48 73 98 123 148 173 198 223 248 273 Market Share Gross Revenue ($M) Net Revenue ($M) Revenue Forecast
Challenge The problem About Us Solution Market Ask Time Counts Roadmap img 02:30

ROADMAP ClinicalValidation International Clinical Pivot Studies FDA’s 510(K) Design Freeze Commercial Production Beta Prototype 1st Year 2nd Year 3rd Year 4th Year Clinical Trials ROADMAP ClinicalValidation International Clinical Pivot Studies FDA’s510(K) Design Freeze Commercial Production Beta Prototype 1st Year 2nd Year 3rd Year 4th Year Clinical Trials
Challenge The problem About Us Solution Market Ask Time Counts Roadmap img 03:00
Ask

$2 million for the production of a beta
prototype and for clinical validation,
reaching results equivalent to or better
than 95%
in accordance with the gold
standard.

img
Challenge The problem About Us Solution Market Ask Time Counts Roadmap img 03:30

TIME COUNTS

Let's create a healthier and safer world.

Challenge The problem About Us Solution Market Ask Time Counts Roadmap 04:00